Sana Biotechnology SANA Cash Flow Statement (2020-2026)

NASDAQ SANA
$3.85 -0.07 (-1.79%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Sana Biotechnology Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Sana Biotechnology reported cash from operations of -$32.79M and free cash flow of -$34.41M for the quarter ended Jun 2026, up 0.9% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-83.27M-113.08M-35.49M-74.08M-85.01M-72.98M-81.86M-113.92M0.68M-87.89M-107.69M-46.17M-59.18M-49.21M-49.64M-94.40M-42.51M-59.92M-47.66M-64.29M
Share-based Compensation
17.28M13.74M24.83M25.62M25.54M10.59M29.20M30.30M29.39M7.93M30.23M30.27M28.48M6.44M25.55M25.01M23.36M6.34M27.88M28.43M
Gains from Investment Securities
8.50M21.76M-0.53M-3.80M-8.30M9.25M5.46M5.90M-58.60M6.45M5.38M3.40M0.20M-2.89M1.86M6.30M2.00M8.58M10.74M16.40M
Asset Writedowns and Impairment
1.89M
Non-cash Items
68.80M
Cash from Operations
-50.49M-110.10M-77.71M-71.48M-64.80M-76.07M-79.27M-58.80M-63.55M-51.96M-65.63M-58.54M-51.82M-47.16M-48.66M-33.10M-29.43M-32.64M-37.38M-32.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
1.76M2.25M2.61M3.08M3.18M3.25M3.35M3.40M3.28M3.23M3.34M2.05M2.11M2.18M2.23M2.23M2.32M2.39M2.47M0.49M
Change in Working Capital
Change in Account Payables
1.77M-1.66M1.92M-1.25M1.48M-1.09M-0.35M0.44M2.28M-1.34M-1.06M0.67M-0.51M2.28M-4.22M1.23M-0.36M-0.19M0.45M-0.85M
Change in Accured Expenses
3.52M-2.06M-2.46M3.40M7.89M2.08M-10.34M6.57M2.08M0.17M-9.82M5.14M-0.68M-3.03M-8.89M-2.99M1.39M5.76M-7.09M1.12M
Other Working Capital Changes
1.27M-2.12M3.19M-2.53M-1.23M6.56M0.11M-5.53M-0.13M-2.58M2.38M5.08M-0.68M-3.27M-1.37M0.63M-1.12M0.70M-1.63M-0.29M
Investing Activities
Capital Expenditures
8.06M5.20M7.53M4.39M4.35M4.60M2.18M1.58M6.18M10.10M15.85M13.06M4.09M0.44M0.14M-0.11M0.04M0.87M0.29M1.62M
Sales of Property, Plant and Equipment
0.25M0.38M0.14M0.66M0.25M0.02M
Change in Acquisitions & Divestments
71.05M13.06M45.75M102.41M53.83M108.14M85.33M95.04M113.93M55.48M53.01M81.50M81.84M60.60M18.17M7.19M1.41M19.80M55.06M15.75M
Cash from Investing Activities
-185.90M-73.66M12.54M77.73M31.86M88.43M62.73M42.63M51.35M15.31M-77.23M5.82M41.77M47.09M16.60M7.68M-48.02M-16.50M49.44M-87.52M
Financing Activities
Other financing activities
0.65M1.58M0.90M1.18M0.24M2.49M0.19M1.71M4.93M3.44M1.94M0.70M1.13M0.33M0.16M1.06M0.06M0.24M
Debt Issuance and Repayment
Long-Term Debt Issuances
0.17M-0.06M-0.09M-0.09M
Change in Capital Stock
Net Shares Issued and Repurchased
4.17M8.04M11.95M6.07M8.43M5.55M7.83M4.68M7.15M5.43M
Net Equity Issued and Repurchased
0.65M1.58M0.90M1.18M0.24M2.49M0.19M24.10M180.00M1.03M-0.03M0.50M28.60M17.00M68.60M
Misc.
Cash from Financing Activities
1.60M3.12M0.65M1.58M1.62M1.06M0.24M29.50M0.19M1.72M186.40M10.63M2.08M0.64M0.98M0.56M109.54M17.65M-0.13M93.58M
Change in Cash
-234.79M-180.64M-64.51M7.83M-31.32M13.42M-16.31M13.33M-12.02M-34.93M43.54M-42.10M-7.96M0.57M-31.07M-24.86M32.09M-31.49M11.93M-26.73M
Free Cash Flow
-58.55M-115.30M-85.24M-75.87M-69.15M-80.67M-81.45M-60.38M-69.73M-62.06M-81.48M-71.60M-55.91M-47.60M-48.79M-32.99M-29.47M-33.51M-37.67M-34.41M
Net Cash Flow
-234.79M-180.64M-64.51M7.83M-31.32M13.42M-16.31M13.33M-12.02M-34.93M43.54M-42.10M-7.96M0.57M-31.07M-24.86M32.09M-31.49M11.93M-26.73M